S100A9 and cancer: Altogether, these findings suggest an intriguing working model in which loss of Brca1 in cancer cells results in upregulation of S100A9, which, in turn, not only positively regulates S100A9 expression in cancer cells but also acts extracellularly to induce MDSC accumulation.